Swedbank
WST icon

Swedbank’s West Pharmaceutical WST Stock Holding History

Swedbank’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.13M Buy
11,504
+1,081
+10% +$330K ﹤0.01% 600
2026
Q1 		$2.61M Hold
10,423
– – ﹤0.01% 618
2025
Q4 		$2.87M Hold
10,423
– – ﹤0.01% 614
2025
Q3 		$2.73M Hold
10,423
– – ﹤0.01% 599
2025
Q2 		$2.28M Hold
10,423
– – ﹤0.01% 593
2025
Q1 		$2.33M Sell
10,423
-1,172
-10% -$323K ﹤0.01% 606
2024
Q4 		$3.8M Buy
11,595
+4,400
+61% +$1.38M ﹤0.01% 576
2024
Q3 		$2.16M Buy
7,195
+2,220
+45% +$680K ﹤0.01% 606
2024
Q2 		$1.64M Buy
4,975
+80
+2% +$28.3K ﹤0.01% 622
2024
Q1 		$1.94M Hold
4,895
– – 0.02% 472
2023
Q4 		$1.72M Hold
4,895
– – ﹤0.01% 606
2023
Q3 		$1.84M Hold
4,895
– – ﹤0.01% 594
2023
Q2 		$1.87M Hold
4,895
– – ﹤0.01% 596
2023
Q1 		$1.7M Hold
4,895
– – ﹤0.01% 602
2022
Q4 		$1.15M Sell
4,895
-4,300
-47% -$1.02M ﹤0.01% 620
2022
Q3 		$2.26M Hold
9,195
– – 0.01% 576
2022
Q2 		$2.78M Hold
9,195
– – 0.01% 569
2022
Q1 		$3.78M Hold
9,195
– – 0.01% 571
2021
Q4 		$4.33M Buy
9,195
+6,800
+284% +$2.93M 0.01% 577
2021
Q3 		$1.02M Sell
2,395
-10,141
-81% -$4.27M ﹤0.01% 690
2021
Q2 		$4.5M Sell
12,536
-6,300
-33% -$2.08M 0.01% 568
2021
Q1 		$5.31M Buy
+18,836
New +$5.39M 0.01% 535

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
GWI
Grace & White Inc Ny, New York $632M AUM 34.34% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
BZWA
Blue Zone Wealth Advisors Los Angeles, California $573M AUM 22.86% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Swedbank's WST Position: Q2 2026 in Review

Swedbank increased its West Pharmaceutical (WST) stake by 10% in Q2 2026, buying an estimated $330K and bringing the position to 11,504 shares worth $4.13M. The position accounts for ﹤0.01% of the portfolio, ranked #600.

Swedbank first reported a position in WST in Q1 2021 and has held it in 22 quarters since. The position peaked at $5.31M in Q1 2021. 97 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Swedbank held 11,504 shares of West Pharmaceutical worth $4.13M as of Q2 2026.
  • Swedbank bought 1,081 West Pharmaceutical shares in Q2 2026, an estimated $330K.
  • West Pharmaceutical made up ﹤0.01% of Swedbank's portfolio in Q2 2026, its #600 holding.
  • Swedbank first reported a position in West Pharmaceutical in Q1 2021 and has held it in 22 quarters since.
  • Swedbank's West Pharmaceutical position peaked at $5.31M in Q1 2021.
  • 97 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.